Zealand Pharma’s drug for rare metabolic disease smashes phase III
After a year of slumping stock prices, Zealand Pharma is striking back, as its peptide…
20/05/2022 - 4 minutes
News and Trends
ADVERTISEMENT
Do you want to remove this advert? Become a member!
Evotec, Sernova in partnership to develop beta cell diabetes therapy
Evotec and Sernova are set to join forces to advance a beta cell replacement therapy…
19/05/2022 - 3 minutes
F2G enlists Shionogi to bring antifungal treatment to Europe and Asia
The UK company F2G Ltd. has announced a strategic collaboration with Japanese pharmaceutical company Shionogi…
19/05/2022 - 4 minutes
US Giant Apollo Bags Billion-Euro Partnership with Sofinnova
As biotech investment slows following a record-breaking year, the Paris-based Sofinnova Partners has landed a…
17/05/2022 - 3 minutes
Valneva’s Covid-19 Vaccine Contract in Dire Straits as EU Approval Lags
The stock price of the French Covid-19 vaccine maker Valneva has been knocked down by…
16/05/2022 - 3 minutes
Domain Therapeutics Bags €39M to Block GPCRs in Cancer Immunotherapy
Domain Therapeutics, a biopharmaceutical company in France and Canada developing cancer immunotherapies targeting G protein-coupled…
13/05/2022 - 4 minutes
The Top European Biotech Investments in April 2022
Private biotech investments in Europe were on a steady decline in April 2022 as biotech…
12/05/2022 - 4 minutes
eureKARE Launches €150M Merger to Form Cell and Gene Therapy CDMO
The French startup creator eureKARE has set up a special purposes acquisition company (SPAC) with…
10/05/2022 - 4 minutes
Melt&Marble Gains €5M to Brew Fat Alternatives Using Engineered Yeast
Tapping into the increasingly sophisticated market for meat alternatives, the Swedish synthetic biology startup Melt&Marble…
06/05/2022 - 4 minutes
Amphista Lands Megadeals to Smash Cancer using Protein Degradation
As big pharma companies flock to drugs that destroy harmful proteins, the UK protein degradation…
05/05/2022 - 3 minutes
Tubulis Rides Investment Wave in ADCs with €60M Series B
The German firm Tubulis has raised a €60M Series B round to advance cancer drugs…
03/05/2022 - 3 minutes
Denmark Recruits Lifebit to Boost Personalized Medicine with Genomics
The Danish National Genome Center has teamed up with the UK firm Lifebit to improve…
29/04/2022 - 3 minutes
